Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
227.69
-3.89 (-1.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...
Via
Benzinga
Exposures
Product Safety
Biogen: Q2 Earnings Insights
July 22, 2021
Shares of Biogen (NASDAQ:BIIB) fell 0.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 44.64% over the past year to...
Via
Benzinga
Biogen's Q2 Profit Falls 70% As Tecfidera Competition Hits Topline
July 22, 2021
Biogen Inc (NASDAQ: BIIB) posted Q2 adjusted EPS of $5.68 ahead of the consensus estimate of $4.55, but quarterly profit fell around 71% Y/Y to $448.5 million as...
Via
Benzinga
What 18 Analyst Ratings Have To Say About Biogen
July 16, 2021
Within the last quarter, Biogen (NASDAQ:BIIB) has observe...
Via
Benzinga
Biogen Earnings, Sales Top Q2 Views; Stock Rises
July 22, 2021
Biogen earnings and sales fell, but beat Q2 views. Biogen stock rose slightly.
Via
Investor's Business Daily
Here's Why Cassava Sciences Is Surging Today
July 21, 2021
Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference.
Via
The Motley Fool
Exposures
Product Safety
SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars
July 21, 2021
SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates.
Via
InvestorPlace
Understanding Biogen's Unusual Options Activity
July 21, 2021
Biogen (NASDAQ:BIIB) shares experienced unusual options activity on Wednesday. The stock price moved down to $322.07 following the option alert. Sentiment: BULLISH Option Type:...
Via
Benzinga
Biogen, Mirimus Team Up For RNAi-Based Therapeutics For Neurological Indications
July 21, 2021
Mirimus Inc has collaborated with Biogen Inc (NASDAQ: BIIB) to develop RNAi-based therapeutics targeting multiple, undisclosed neurological disease indications....
Via
Benzinga
Earnings Scheduled For July 22, 2021
July 22, 2021
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,...
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
July 21, 2021
Both of these companies have successfully developed breakthrough medicines.
Via
The Motley Fool
Carnival And American Airlines Lead The SPY Higher Tuesday
July 20, 2021
U.S. indices were trading higher Tuesday amid a rebound in reopening stocks, which dipped Monday amid Delta variant concerns. The...
Via
Benzinga
Is It Too Late to Buy Biogen Stock?
July 19, 2021
This biotech company could be a diamond in the rough -- for investors who can tolerate its share price volatility.
Via
The Motley Fool
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week...
Via
Benzinga
Exposures
Product Safety
4 Large-Cap Healthcare Stocks You'll Want on Your Radar for the Second Half of 2021
July 18, 2021
There are important things to watch with each of these stocks.
Via
The Motley Fool
Exposures
COVID-19
Week In Review: Innocare Strikes $937 Million Deal With Biogen For BTK Inhibitor
July 17, 2021
Beijing InnoCare out-licensed ex-China rights for its BTK inhibitor to Biogen in a $937.5 million deal. Biogen will pay $125 million upfront and up to $812.5 million in milestones, plus royalties.
Via
Talk Markets
Stock Market Rally Struggles Outside Apple; JPMorgan, Goldman, UnitedHealth, Taiwan Semi Are Key Earnings
July 16, 2021
Apple hit record highs, but the stock market quietly struggled this week. JPMorgan, Goldman, Taiwan Semi kicked off earnings.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
FibroGen Stock Collapses After FDA Panel Rejects Anemia Treatment
July 16, 2021
A FDA panel voted resoundingly against recommending approval for an anemia treatment from FibroGen, and FGEN stock tanked on Friday.
Via
Investor's Business Daily
Exposures
Product Safety
Better Biotech Stock: Biogen vs. Annovis Bio
July 16, 2021
Both are making Alzheimer's drugs, but only one can claim success as of today.
Via
The Motley Fool
AMD And Biogen Lead The QQQ Lower Thursday
July 15, 2021
U.S. indices were trading lower Thursday as investors weigh Fed Chair Powell’s comments on inflation to the Senate banking panel. ...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
BIIB Stock: The Drug Ban News That Has Biogen Stumbling Today
July 15, 2021
BIIB stock is losing out today, as two major hospitals have declined to use Biogen's controversial new Alzheimer's drug on their campuses.
Via
InvestorPlace
Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration
July 15, 2021
A pair of large hospitals have declined to administer Biogen Inc’s (NASDAQ: BIIB) Alzheimer’s treatment Aduhelm, Wall Street Journal reported. The...
Via
Benzinga
Biogen Stock Dives After Cleveland Clinic, Mount Sinai Ban Alzheimer's Drug Aduhelm
July 15, 2021
Biogen stock tumbled Thursday after the Cleveland Clinic and Mount Sinai said they won't administer the company's Alzheimer's drug, Aduhelm.
Via
Investor's Business Daily
Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News
July 15, 2021
Acting FDA Commissioner Janet Woodcock pushed back against media questions about the agency's controversial approval of Alzheimer's treatment, Aduhelm developed by ...
Via
Benzinga
Exposures
Product Safety
Biogen Stock And The Aduhelm Drama: Will It Really Treat Alzheimer's?
July 15, 2021
The fate of Biogen stock is now intricately tied to the success — or failure — of its controversial Alzheimer's treatment, Aduhelm.
Via
Investor's Business Daily
US Medicare Starts Coverage Policy Review For Biogen's Aduhelm
July 13, 2021
The U.S. government started a review process for national Medicare coverage of Biogen Inc's (NASDAQ: BIIB) Alzheimer's drug, Aduhelm. The Centers for...
Via
Benzinga
Biogen, InnoCare Collaborate On Multiple Sclerosis Candidate
July 13, 2021
Biogen Inc (NASDAQ: BIIB) is paying $125 million upfront to work on InnoCare Pharma Limited's orelabrutinib, a small oral molecule Bruton's...
Via
Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
Tesla And Lam Research Lead The QQQ Higher Monday
July 12, 2021
Major U.S. indices managed to all finish with record closing highs Monday as investors continue to weigh last week’s sell-off over conce...
Via
Benzinga
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.